ReportLinker logo.jpg
Source: ReportLinker

Global Non-invasive Prenatal Testing Market By Application, By Product, By Technology, By End User, By Region, Forecast & Opportunities, 2025

This report is 80% complete and can be delivered within three working days post order confirmation and will include the latest impact analysis of Covid-19 in 2020 and forecast. Global Non-invasive Prenatal Testing (NIPT) Market By Application (Trisomy (Down syndrome, Edwards syndrome, Patau syndrome), Turner syndrome, Rh Blood type and Others), By Product (Instruments, Kits and assay), By Technology (Cell free fetal DNA technology, Massively parallel sequencing, Target Capture Sequences Technology and others), By End User (Hospitals and diagnostic laboratory), By Region, Forecast & Opportunities, 2025

New York, July 01, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Non-invasive Prenatal Testing Market By Application, By Product, By Technology, By End User, By Region, Forecast & Opportunities, 2025" - https://www.reportlinker.com/p05916715/?utm_source=GNW

Global non-invasive prenatal testing (NIPT) market is expected to witness a robust growth during the forecast period.Increasing genetic disorders in pre-borne children and growing population are the major factors for the growth of the market.

Additionally, rise in maternal age and technology advancement have also boosted the demand of NIPT solutions as parents wants to ensure that their baby is free from all disorders and earlier diagnosis assist in that. However, high maintenance and lack of competent professionals are major factors restraining the growth of the market across the globe.

The global non-invasive prenatal testing (NIPT) market is segmented based on application, product, technology, end user and region. The application segment is further segmented into trisomy, turner syndrome, Rh blood type and others, out of which trisomy held the dominant share in 2019 due to the increasing prevalence of Down’s syndrome, Edward’s syndrome and Patau syndromes in unborn children.

In terms of regional analysis, North America led the market in 2019.The factors responsible for the dominance of North America include heavy funding by the government and presence of leading market players in the region.

On the other hand, Asia-Pacific is anticipated to grow at the fastest rate in the coming years due to increasing awareness about prenatal testing among population.

Leading players in the global non-invasive prenatal testing (NIPT) market include Roche, Integrated Genetics, Natera, BGI Genomics, Illumina, Invitae, Genesis Genomics, PerkinElmer, Eurofins Scientific, Thermo Fisher Scientific, Agilent Technologies, Yourgene Health, Berry Genomics, Igenomix, Quest Diagnostics, Asper Biogene, Myriad Genetics, Progenity, Fasteris, Bionet Corp, etc. In order to maintain their position in the market and to generate large revenues, leading players tend to adopt various organic and inorganic strategies like mergers and acquisitions.

Years considered for this report:

Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021–2025

Objective of the Study:

• To analyze and forecast the market size of global non-invasive prenatal testing (NIPT) market.
• To classify and forecast global non-invasive prenatal testing (NIPT) market based on application, product, technology, end user and region and company.
• To identify drivers and challenges for global non-invasive prenatal testing (NIPT) market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global non-invasive prenatal testing (NIPT) market.
• To conduct pricing analysis for global non-invasive prenatal testing (NIPT) market.
• To identify and analyze the profile of leading players operating in global non-invasive prenatal testing (NIPT) market.
The analyst performed both primary as well as exhaustive secondary research for this study.Initially, the analyst sourced a list of hospitals and clinics performing non-invasive prenatal testing across the globe.

Subsequently, the analyst conducted primary research surveys with the identified companies.While interviewing, the respondents were also enquired about their competitors.

Through this technique, the analyst could include the hospitals and clinics performing non-invasive prenatal testing which could not be identified due to the limitations of secondary research. The analyst examined the hospitals and clinics performing non-invasive prenatal testing and presence of all major players across the globe.
The analyst calculated the market size of global non-invasive prenatal testing (NIPT) market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The analyst sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size.

Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the analyst.

Key Target Audience:

• Non-invasive prenatal testing (NIPT) hospitals, clinics and laboratories and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to non-invasive prenatal testing (NIPT)
• Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals and clinics performing non-invasive prenatal testing, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global non-invasive prenatal testing (NIPT) market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Market, By Application:
o Trisomy (Down Syndrome, Edwards Syndrome, Patau Syndrome)
o Turner Syndrome
o Rh Blood Type
o Others
• Market, By Product:
o Instruments
o Kits
o Assay
• Market, By Technology:
o Cell Free Fetal DNA Technology
o Massively Parallel Sequencing
o Target Capture Sequences Technology
o Others
• Market, By End User:
o Hospitals
o Diagnostic Laboratory
• Market, By Region:
o Asia-Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Australia
o Europe
- France
- Germany
- United Kingdom
- Italy
o North America
- United States
- Mexico
- Canada
o South America
- Brazil
- Argentina
- Colombia
o Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global non-invasive prenatal testing (NIPT) market.

Available Customizations:

With the given market data, we offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).


Read the full report: https://www.reportlinker.com/p05916715/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________